Rebornne First Colostrum Southpole Sunlife Colostrum The world Colostrum Company
|
|
||||||
|
Colostrum Research(Bovine Colostrum):What is in Colostrum?Immune Factors: Medical and clinical studies show immune factors in colostrum fight viruses, bacteria, yeast, fungus, allergens and other toxins. Immunoglobulins: Antibodies: PRP (Proline-rich Polypeptide): Lactoferrin: Glycoproteins: (protease and
trypsin inhibitors) Lactalbumins: Cytokines: Lysozymes: Growth Factors: Epithelial Growth Factor (EGF): Insulin-like Growth Factor I and II: (IGF-I
& IGF-II) Transforming Growth Factors A & B: (TGF
A & B) Platelet-Derived Growth Factor: (PDGF) Vitamins & Minerals Athletic PerformanceBuckley JD, et al. Effect of An Oral Bovine Colostrum Supplement Intact on Running Performance. Burke E. (1996) Colostrum as an athletic enhancer and help for AIDS. Nutrition Science News. Mero A, et al. (1997) Effects of bovine colostrum supplementation
on serum IGF-1, IgG, hormone, and saliva IgA during training. Journal
of Applied Physiology. 83: 1144-1151. Sparling PB, Nieman DC, O'Connor PJ. (1993) Selected scientific
aspects of marathon racing : an update on fluid replacement, immune function,
psychological factors and the gender difference. Sports Medicine.
15: 116-132. Berk LS, Nieman DC, Youngberg WS, et al. (1989) The effect
of long endurance running on natural killer cells in marathoners. Medicine
and Science in Sports and Exercise. 22: 207-212. Antonio, J., Sanders, M. and Van Gammeren, D. The Effects
of Bovine Colostrum Supplementation on Body Composition and Exercise Performance
in Active Men and Women. Nutrition 17:243-247, 2001. General InformationBitzan MM, Gold BD, Philpott DJ, et al. (1998) Inhibition
of Helicobacter pylori and Helicobactor mustelae binding to lipid receptors
by bovine colostrum. The Journal of Infectious Diseases. 177: 955-961. Cavalli-Sforza LT, Strata A. (1987) Double-blind study on
the tolerance of four types of milk in lactose malabsorbers. Human
Nutrition: Clinical Nutrition 40C: 19-30. Joseph M. and Flesch A. (1998) Research shows colostrum to be one of nature's most potent, broad-spectrum substances. Chiropractic Journal.
Cenacchi T, Baggio C, and Palin E. (1987) Human tolerability of oral phosphatidylserine assessed through laboratory examinations. Clinical Trials Journal. 24. Ghidini A, Hicks C, Lapinski RH, Lockwood CJ. (1997) Morbidity
in the preterm infant with mature lung indicies. American Journal of
Perinatology. 14: 75-78. Jochims K, Kaup FJ, Drommer W. (1994) Immunoelectron microscopical
demonstration of the absorption of colostral IgG by small intestinal enterocytes
in newborn rats. Research in Veterinary Science. 57: 146-151. Efigenia M, Povoa B, Moraes-Santos T. (1997) Effect of heat treatment on the nutritional quality of milk proteins. International Dairy Journal. 7:609-612.
Klagsbrun, M. (1978) Human milk stimulates DNA synthesis and
cellular proliferation in cultured fibroblasts. Proceedings of the
National Academy of Sciences, USA. 75: 5057-5061. Kume S, Tanabe S. (1993) Effect of parity on colostral mineral
concentrations of holstein cows and value of colostrum as a mineral source
for newborn calves. Journal of Dairy Science. 76:1654-1660. Le Dividich J, Herpin P, Paul E, Strullu F. (1997) Effect
of fat content of colostrum on voluntary colostrum intake and fat utilization
in newborn pigs. Journal of Animal Science. 75:707-713. Li-Chan E, Kummer A, Losso J, Kitts D, Nakai S. (1995) Stability of bovine immunoglobulins to thermal treatment and processing. Food Research International. 28: 9-16. Nitsch A, and Nitsch F. (1998) The clinical use of bovine colostrum. Journal of Orthomolecular Medicine. 13. Wit JN. (1998) Nutritional and functional characteristics
of whey proteins in food products. Journal of Dairy Science. 81:597-608. Walker WA. (1999) What is the role of nucleotides and polyamines
in breast milk? Acta Paediatrica. 88:1313-1315. McConnell MA, Brooks HJL, Borissenko MB, Buchan GA. A comparative study of immunoglobulin levels and anti-inflammatory activity in four milk products. Journal of Dairy Science, Publication forthcoming.
Warny M, Fatima A, Bostwick E, et al. (1998) Bovine immunoglobulin
concentrate-Clostridium difficile retains C difficile toxin neutralising
activity after passage through the human stomach and small intestine.
Gut. 44(2):212-7. Wieczorek Z, Zimecki M, Janusz M, Staroscik K, Lisowski J.
(1979) Proline-rich polypeptide from ovine colostrum: its effect on skin
permeability and on the immune system. Immunology. 36:879-881. Yamamoto A, Wada O, Suzuki H. (1987) Purification and properties
of biologically active chromium complex from bovine colostrum. American
Institute of Nutrition. 118(1):39-45. Zhang T, Iguchi K, Mochizzuki T, Hoshino M, Yanaihara C, Yanaihara
N. (1990) Gonadotropin-releasing hormone-associated peptide immunoreactivity
in bovine colostrum. Society for Experimental Biology and Medicine.
194(3):270-3. Growth FactorsAntonio J. (1998) Can bovine colostrum enhance levels of IGF-1? Muscle and Fitness. Ballard F, Wallace J, Francis G, Read L, Tomas F. (1996) Des
(1-3) IGF-I: a truncated form of insulin-like growth factor-I. International
Journal of Cellular Biology. 28:1085-1087. Bricker D. (1991) Colostrum: Implications for accelerated recovery in damaged muscle and cartilage, prevention of some pathogenic disease. The American Chiropractor. Burrin D, Davis T, Ebner S, Schoknecht P, Fiorotto M, Reeds
P. (1997) Colostrum enhances the nutritional stimulation of vital organ
protein synthesis in neonatal pigs. American Society for Nutritional
Sciences. 127(7):1284-9. Bhora F, Dunkin, B, Batzri S, et al. (1995) Effect of growth
factors on cell proliferation and epithelialization in human skin.
Journal of Surgery Res. 59:236-244.
Burrin DG, Shulman RJ, Reeds PJ, Davis TA, Gravitt KR. (1992)
Porcine colostrum and milk stimulate visceral organ and skeletal muscle
protein synthesis in neonatal piglets. Journal of Nutrition. 122:1205-1213. Cass TL. Insuin-like growth factor-1 (IGF-1, Somatomedin C) blood levels are not associated with prostate specific antigen (PSA) levels or prostate cancer: A study of 749 patients. Medical College of Wisconsin, Milwaukee, WI www.worldhealth.net/news/prost-igf1/:1999. Demarco C. (1998) Anti-aging breakthrough: Homeopathic growth factors. Let's Live. Francis G, Upton F, Ballard J, McNeil K, Wallace J. (1988)
Insulin-like growth factors 1 and 2 in bovine colostrum. Journal of
Biochemistry. 251:95-103. Fryburg D. (1995) Insulin and insulin-like growth factor 1
enhance human skeletal muschle protein anabolism during Hyperaminoacidemia
by different mechanisms. Journal of Clinical Investigations 96:1722-1729. Francis G, Read L, Ballard J, et al. (1986) Purification and
partial sequence analysis of insulin-like growth factor-1 from bovine
colostrum. Journal of Biochemistry 233:207-213. Ginjala V, Pakkanen R. (1998) Determination of transforming
growth factor-B1 (TGF-B1) and insulin-like growth factor 1 (IGF-1) in
bovine colostrum samples. Journal of Immunoassay 19:195-207.
Hadsell KL, Baumrucker CR, Kensinger RS. (1993) Effects of
elevated blood insulin-like growth factor-I (IGF-I) concentration upon
IGF-I in bovine mammary secretions during the colostrum phase. Journal
of Endocrinology. 137:223-230. Juskevich J. (1990) Bovine Growth Hormone: Human Food Safety Evaluation. Science. 249:875-883. Kirkpatrick CH.(1993) Structural nature and functions of transfer
factors. Annals New York Academy of Sciences. 685:362-8. Marcotty C, Frankenne F, Van Beeumen J, Maghuin-Rogister G,
Hennen G. (1991) Insulin-like growth I (IGF-I) from cow colostrum: Purification
and characterization. Growth Regulation. 1(2):56-61. Marquardt H, Lioubin MN, Ikeda T. (1987) Complete amino acid
sequence of human transforming growth factor type beta 2. Journal of
Biological Chemistry. 262:12127-12131. Miers W, Barrett E. (1998) The role of insulin and other hormones
in the regulation of amino acid and protein metabolism in humans. Journal
of Basic and Clinical Physiology and Pharmacology. 9(2-4):235-53.
Noda K, Umeda M, Ono T. (1984) Transforming growth factor
activity in human colostrum. Gann. 75:109-112. Nowak J, Olszewski J, Kozal E. (1994) Insulin and sugar concentration
changes in mammary secretion in sheep during the periparturient period.
Reprod. Nutritional Development. 34:3-8. Nowak J. (1990) Insulin and glucose concentration changes
in newborn piglets after suckling the colostrum from insulin administered
sows. Acta Physiol. 41(7):155-62. Nord J, Ma P, DiJohn D, Tzipori S, Tacket CO. (1990) Treatment
with bovine hyperimmune colostrum cryptosporidial diarrhea in AIDS patients.
AIDS. 4:581-584. Oda S, Satoh H, Sugawara T, et al. (1989) Insulin-like growth
factor-I, GH, insulin and glucagon concentrations in bovine colostrum
and in plasma of dairy cows and neonatal calves around parturition. Comp.
Biochemical Physiology. 94A:805-808. Pakkanen R, Aalto J. (1997) Review paper: Growth factors and antimicrobial factors of bovine colostrum. International Dairy Journal. 7:285-297. Pakkanen R. (1998) Determination of transforming growth factor-B2 (TGF-B2) in bovine colostrum samples. Journal of Immunoassay. 19:23-37. Rosenthal S, Brown E, Brunetti A, Goldfine I. (1991) Fibroblast
growth factor inhibits insulin-like growth factor-II (IGF-II) gene expression
and increases IGF-I receptor abundance in BC3H-1 muscle cells. Molecular
Endocinology. 5:678-684. Russell J, Feldman E. (1999) Insulin-like growth factor-I
prevents apoptosis in sympathetic neurons exposed to high glucose. Horm
Metab Res. 31:90-96. Sara VR, Hall K. (1990) Insulin-like growth factors and their binding proteins. Physiological Reviews. 70:591-606. Shimizu M, Webster C, Morgan DO, Blau HM, Roth RA. (1986) Insulin and insulin-like growth factor receptors and responses in cultured human muscle cells. American Journal of Physiology. 251:E611-5. Shing Y, Klagsbrun M. (1987)Purification and characterization
of a bovine colostrum-derived growth factor. Molecular Endocrinology.
1:335-338. Skottner A, Arrhenius-Nyberg V, Kanje M, Fryklund L. (1990)
Anabolic and tissue repair functions of recombinant insulin-like growth
factor I. Acta Pediatric Scand. 367:63-66.
Sporn M, Roberts A, Shull J, Smith J, Ward J. (1983) Polypeptide
transforming growth factors isolated from bovine sources and used for
wound healing in vivo. Science. 219(4590): 1329-31. Tokuyama H, Tokuyama Y, Migita S. (1990) Isolation of two
new proteins from bovine colostrum which stimulates epidermal growth factor-dependent
colony formation of NRK-49F cells. Growth Factors. 3(2):105-14. Tokuyama Y. (1993) Purification and identification of TGF-B2-related
growth factor from bovine colostrum. Journal of Dairy Research.
60:99-109. Tollefsen S, Lajara R, McCusker R, Clemmons D, Rotwein P.
(1989) Insulin-like growth factors (IGF) in muscle development. Journal
of Biological Chemistry. 264(23):13810-7. Tomas F, Knowles S, Owens P, et al. (1991 ) Increased weight
gain, nitrogen retention and muscle protein synthesis following treatment
of diabetic rats with insulin-like growth factor (IGF)-I and des(1-3)IGF-I.
Biochem J. 276 ( Pt 2):547-54. Tokuyama, H. and Tokuyama, Y. (1989) Bovine colostric transforming
growth factor-B like peptide that induces growth inhibition and changes
in morphology of human osteogenic sarcoma cells (MG-63). Cell Biology
International Reports 13:251-258.
Ullman M, Ullman A, Sommerland H, Skottner A, Oldfors A. (1990) Effects of growth hormone on muscle regeneration and IGF-I concentration in old rats. Acta Physiological Scand 140:521-525. Shomali M, Wolfsthal S. (1997) The use of anti-aging hormones.
Maryland Medical Journal 46:181-186. Watson DL, Francis GL, Ballard FJ. (1992) Factors in ruminant
colostrum that influence cell growth and murine IgE antibody responses.
Journal of Dairy Research 59:369-380. Immune FactorsBocci V, Von Bremen K, Corradeschi F, Luzzi E, Paulesu L.
(1991) What is the role of cytokines in human colostrum? Journal of
Biological Regulators and Homeostatic Agents. 3:121-124. Boesman-Finkelstein M. and Finkelstein R. (1989) Passive oral
immunisation of children. Lancet. 2(8675):1336. Bogstedt AK, Johansen K, Hatta H, et al. (1996) Passive immunity
against diarrhoea. Acta Paediatr. 85:125-128.
Casswall T, Sarker S, Albert M, et al. (1998) Treatment of
Helicobacter pylori infection in infants in rural Bangladesh with oral
immunoglobulins from hyperimmune bovine colostrum. Ailment Pharmacol
Therapies 12:563-568. Davidson G, Whyte P, Daniels E, et al. (1989) Passive immunisation
of children with bovine colostrum containing antibodies to human rotavirus.
Lancet. 2(8665):709-12. Dichtelmuller W, Lissner R. (1990) Antibodies from colostrum
in oral immunotherapy. Journal of Clinical Biochemistry 28:19-23. Ebina T, Umezu K, Ohyama S, et al. (1983) Prevention of rotavirus
infection by cow colostrum containing antibody against human rotavirus.
Lancet. 2(8357):1029-30. Feldmann M, Brennan F, Maini R. Role of cytokines in rheumatoid
arthritis. Annual Review of Immunology 14:397-440, 1996. Hanson LA, Ahlstedt S, Andersson B, et al. (1983) Mucosal Immunity. Annals New York Academy of Sciences 83:1-20. Boesman-Finkelsein M, Walton NE, Finkelstein RA. (1989) Bovine
lactogenic immunity against cholera toxin-related enterotoxins and Vibrio
cholerae outer membranes. Infection and Immunity 57:1227-1234. Hilpert H, Brussow H, Mietens C, Sidoti J, Lerner L, Werchau
H. (1987) Use of bovine milk concentrate containing antibody to rotavirus
to treat rotavirus gastroenteritis in infants. Journal of Infectious
Diseases 156:158-166.
Hirmo S, et al. (1998) Characterization of Helicobacter pylori
interactions with sialylglycoconjugates using a resonant mirror biosensor.
Analytical Biochemistry 257:63-6. Hoffman M. (1992) Transferred immune cells may help fight
viral infection. Immunology. 257(5067):166. Honorio-Franca A, Carvalho M, Isaac L, Trabulsi L, Carneiro-Sampaio
M. (1997) Colostral mononuclear phagocytes are able to kill enteropathogenic
Escherichia coli opsonized with colostral IgA. Scandavian Journal of
Immunology. 46:59-66. Huppertz H, Rutkowski S, Busch D, Eisebit R, Lissner R, Karch
H. (1999) Bovine colostrum ameliorates diarrhea in infection with diarrheagenic
Escherichia coli, shiga toxin producing E. coli, and E-coli expressing
intimin and hemolysin. Journal of Pediatric Gastroenterology and Nutrition.
29:452-456. Janusz M, Lisowski J. (1993) Proline-rich polypeptide (PRP)-an immunomodulatory peptide from ovine colostrum. Archivum Immunologiae et Therapiae Experimentalis. 41:275-279. Jochims K, Kaup F, Drommer W, Pickel M. (1994) An immunoelectron
microscopic investigation of colostral IgG absorption across the intestine
of newborn calves. Research in Veterinary Science. 57:75-80.
Kelly CP, et al. (1996) Anti-Clostridium difficile bovine
immunoglobulin concentrate inhibits cytotoxicity and enterotixicity of
C. difficile toxins. Antimicrobial Agents and Chemotherapy 40:373-379. Kelly G. (1999) Larch arabinogalactan: Clinical relevance
of a novel immune-enhancing polysaccharide. Alternative Medicine Review.
4(2):96-103. Khazenson L, Gennad'eva T, Roshchin V, Krasheniuk A, Semenova
N. (1980) Activity of bovine colostral IgG in the human digestive tract.
ZH Mikrobiol Epidemiol Immunobiol 9:101-106. Kohl S, Malloy, M, Pickering L, Morriss F, Adcock E, Walters
D. (1978) Human colostral cytotoxicity: I. Antibody-dependent cellular
cytotoxicity against herpes simplex viral-infected cells mediated by colostral
cells. Journal of Clinical Laboratory Immunology. 1:221-224. Korhonen H, Suvaoja EL, Ahola-Luttilia H, et al. (1995) Bactericidal
effect of bovine normal and immune serum, colostrum and milk against Helicobactor
pylori. Journal of Applied Bacteriology 78:655-662. Lawton JW, Shortridge KF, Wong RL, Ng MH. (1979) Interferon
synthesis by human colostral leucocytes. Archives of Disease in Childhood
54:127-130.
LeFranc-Millot C, Vercaigne-Marko D, Wal J.-M, et al. (1996)
Comparison of the IgE titers to bovine colostral G immunoglobulins and
the F(ab')2 fragments in sera of patients allergic to milk. Int Arch
Allergy Immunol. 110:156-162. Leszek J, Inglot AD, Janusz M, Lisowski J, Krukowska K, Georgiades
JA. (1999) Colostrinin: a Proline-Rich Polypeptide (PRP) Complex Isolated
from Ovine Colostrum for Treatment of Alzheimer's Disease. A Double -
Blind Placebo-Controlled Study. Archivum Immunologiae et Therapiae
Experimentalis. 47(6):377-85. Lissner R, Thurmann P, Merz G, Karch, H. (1998) H. Antibody
reactivity and fecal recovery of bovine immunoglobulins following oral
administration of a colostrum concentrate from cows to healthy volunteers.
International Journal of Clinical Pharmacology and Therapeutics 36:239-245. Loimaranta V, Carlen A, Olsson J, Tenovuo J, Syvaoja E.-L,
Korhonen H. (1998) Concentrated bovine colostral whey proteins from Streptococcus
mutans/Strep. sobrinus immunized cows inhibit the adherence of Strep.
mutans and promote the aggregation of mutans streptococci. Journal
of Dairy Research 65:599-607. McClead RE, Butler T, Rabbani GH. (1988) Orally Administered
Bovine Colostral Anti-Cholera Toxin Antibodies: Results of Two Clinical
Trials. The American Journal of Medicine 85:811-816.
Michalek SM, McGhee JR. (1977) Effective immunity to dental
caries: passive transfer to rats to antibodies to Streptococcus mutans
elicits protection. Infection and Immunity 17:644-650. Michalek SM, McGhee JR, Babb JL. (1978) Effective immunity
to dental caries: dose-dependent studies of secretory immunity by oral
administration of Streptococcus mutans to rats. Infection and Immunity.
19:217-224. Mitra AK, Mahalanabis D, Ashraf H, Unicomb L, Eeckels R, Tzipori
S. (1995) Hyperimmune cow colostrum reduces diarrhoea due to rotavirus:
a double-blind, controlled clinical trial. Acta Paediatr. 84:996-1001. Moro I, Abo T, Crago SS, Komiyama K, Mestecky J. (1985) Natural
Killer Cells in Human Colostrum. Cellular Immunology. 93:467-474. Naber P, et al. (1996) Inhibition of adhesion of Clostridium
difficile to caco-2 cells. Immunology and Medical Microbiology.
14:205-209. Ouwehand A, Salminen S, Skurnik M, Conway P. (1997) Inhibition of pathogen adhesion by B-lactoglobulin. International Dairy Journal. 7:685-692. Ogra P, Losonsky G, Fishaut M. (1983) Colostrum-derived immunity
and maternal-neonatal interaction. New York Academy of Science 409:82-95. Ogra SS, Ogra PL. (1978) Immunologic aspects of human colostrum
and milk. The Journal of Pediatrics. 92:546-549. Palmer EL, Gary Jr. GW, Black R, Martin ML. (1980) Antiviral
activity of colostrum and serum immunoglobulins a and g. Journal of
Medical Virology. 5:123-129. Parodi PW. (1996) Milk fat components: possible chemopreventive agents for cancer and other diseases. The Australian Journal of Dairy Technology. 51:24-32. Petschow B, Talbott R. (1994) Reduction in virus-neutralizing
activity of a bovine colostrum immunoglobulin concentrate by gastic acid
and digestive enzymes. Journal of Pediatric Gastroenterology and Nutrition
. 19:228-235. Plettenberg A, Stoehr.A, Stellbrink.J, Albrecht.H, Meigel
W. (1993) A preparation from bovine colostrum in the treatment of HIV-posotive
patients with chronic diarrhea. Clinical Investigator 71:42-45. Pincus C, Nussenweig V. (1971) Regulation of the Immune Response:
Suppressive and enhancing effects of passively administered antibody.
Journal of Experimental Medicine. 133:987-1003. Pironi L, Miglioli M, Ruggeri E, et al. (1990 ) Relationship
between intestinal permeability to EDTA and Inflammatory activity in asymptomatic
patients with Crohn's disease. Digestive Diseases and Sciences.
35(5):582-8.
Quigley JD, Martin KR, Dowlen HH, Wallis LB, Lamar K. (1994)
Immunoglobulin concentration, specific gravity, and nitrogen fractions
of colostrum from Jersey cattle. Journal of Dairy Science. 77:264-269. Rautiainen E. (1998) The prevalence of Mycoplasma hyopneumoniae
in pig herds in western Finland based on the demonstration of antibodies
in colostrum by ELISA. Acta Vet Scand. 39:325-330. Ritchie D, Becker E. (1994) Update on the management of intestinal
cryptosporidiosis in AIDS. The Annals of Pharmacotherapy. 28:767-778. Robert Service. (1994) Triggering the First Line of Defense.
Research News. 265. Rump JA, Arndt R, Arnold A, et al. (1992)Treatment of diarrhoea
in human immunodeficiency virus-infected patients with immunoglobulins
from bovine colostrum. Clinical Investigator. 70:588-594. Saif L, Smith K. (1985) Enteric viral infections of calves
and passive immunity. Journal of Dairy Science. 68:206-228. Sandholm M, Honkanen-Buzalski T. (1979) Colostral trypsin-inhibitor
capacity in different animal species. Acta Vett.Scand. 20:469-476.
Sarker S, Casswall T, Mahalanabis M, et al. (1998) Successful
treatment of rotavirus diarrhea in children with immunoglobulin from immunized
bovine colostrum. Pediatric Journal of Infectious Disease. 17:1149-54. Savilahti E, Tainio VM, Salmenpera L, Arjomaa P, Kallio M,
Perheentupa J, Siimes MA. (1991) Low colostral IgA associated with cow's
milk allergy. Acta Pediatr Scan. 80:1207-1213. Selo I, Clement G, Bernard H, et al. (1999) Allergy to bovine
B-lactoglobulin: specificity of human IgE to tryptic peptides. Clinical
and Experimental Allergy 29:1055-1063. Shearman D. (1972) The demonstration and function of antibodies
in the gastrointestinal tract. Gut. 13(6):483-99. Shortridge K, Lawton J, Choi E. (1990) Protective potential
of colostrum and early milk against prospective influenza viruses. Journal
of Tropical Pediatrics. 36(2):94-5. Siber G. (1992) Immune globulin to prevent nosocomial infection.
New England Journal of Medicine. 327(4):269-71. Stephen W, Dichtelmuller H, Lissner R. (1990) Antibodies from
colostrum in oral immunotherapy. Journal of Chemical Clinical Biochemistry
28:19-23.
Staroscik K, Janusz M, Zimecki M, Wieczorek Z, Lisowski J.
(1983) Immunologically active nonapeptide fragment of a proline-rich polypeptide
from ovine colostrum: amino acid sequence and immunoregulatory properties.
Molecular Immunology. 12:1277-1282. Swarbrick ET. (1992) The handling of ingested antigens. Am
J Trop Med Hyg. 47(3):276-83. Tacket CO, Binion SB, Bostwick E, Losonsky G, Roy MJ, Edelman R. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am. J. Trop. Med. Hyg. 47:276-283, 1992. Takahashi, T. and et al. (1998) Effects of Orally Ingested
Bifidobacterium longum on the Mucosal IgA response of Mice to Dietary
Antigens. Biosci Biotechnol Biochem. 62(1):10-5. Tejada-Simon M, Lee J, Ustunol Z, Pestka J.( 1999) Ingestion
of yogurt containing lactobacillus acidophilus and bifidobacterium to
potentiate immunoglobulin A responses to cholera toxin in mice. Journal
of Dairy Science 82:649-660. Tyler J, Stevens B, Hostetler D, Holle J, Denbigh J. (1999)
Colostral immunoglobulin concentrations in holstein and guernsey cows.
American Journal of Veterinary Research. 60(9):1136-9. Tzipori S, Roberton D, Chapman C. (1986) Remission of diarrhoea
due to cryptosporidiosis in an immunodeficient child treated with hyperimmune
bovine colostrum. British Medical Journal. 293(6557):1276-7.
Ulcova-Gallova Z, Fialova P, Krauz V. (1994) Immunologic factors
in human colostrum and milk. Casopis Lekaru Ceskych 133:275-276. Ungar BLP, Ward DJ, Fayer R, Quinn CA. (1990)Cessation of
Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome
patient after treatment with hyperimmune bovine colostrum. Gastroenterology
. 98:486-489. Ushijima H, Dairaku M,
Honnma H, Mukoyama A, Kitamura T. (1990) Immunoglobulin components and
anti-viral activities in bovine colostrum. 64:274-279. Veselsky L, Cechova D, Jonakova V. (1978) Secretion and Immunochemical
Properties of the Trypsin Inhibitor from Bovine Colostrum. Hoppe-Seyler's
Z. Physiol. Chem. 359:873-878. Waldman RH, Stone J, Lazzell V, et al. (1983) Oral route as
method for immunizing against mucosal pathogens. Ann N Y Acad Sci.
Jun 30;409:510. Walker M. (1999)Bovine colostrum offers broad-spectrum benefits for wide-ranging ailments. Medical Journalist Report of Innovative Biologics: Townsend Letters for Doctors and Patients. 74-80. Walker M. (1997) Homeostatic soil organisms support immune system functions from the ground up. Townsend Letters for Doctors and Patients. Walker M. (1995) Infectious bugs are back but there's a remedy. Townsend Letters for Doctors and Patients. Ylitalo S, Uhari M, Rasi S, Pudas J, Leppaluoto J. (1998)
Rotaviral antibodies in the treatment of acute rotaviral gastroenteritis.
Acta Paediatr. 87:264-167. Yolken RH. Losonsky GA, Vonderfecht S, Leister F, Wee SB.
(1985) Antibody to human rotavirus in cow's milk. The New England Journal
of Medicine. 312:605-610. Intestinal PermeabilityBitzan MM, Gold BD, Philpott DJ, et al. (1998) Inhibition of Helicobacter pylori and Helicobactor mustelae binding to lipid receptors by bovine colostrum. The Journal of Infectious Diseases 177:955-961. Bjarnason I, Peters TJ, Wise RJ. (1984) The Leaky gut of alcoholism:
Possible route of entry for toxic compounds. The Lancet. 1(8370):179-82. Campieri M, Gionchetti P.( 1999) Probiotics in inflammatory
bowel disease: New insight to pathogenesis or a possible therapeutic alternative.
Gastroenterology 116:1246-1260. Crissinger K., Kvietys P. Granger D. (1990) Pathophysiology
of gastrointestinal mucosal permeability. Journal of Internal Medicine
228:145-154.
Deitch E. (1990) The Role of intestinal barrier failure and
bacterial translocation in the development of systemic infection and multiple
organ failure. Archives of Surgery. 125(3):403-4. Doe W. An overview of intestinal immunity and malabsorption.
American Journal of Medicine. 67:1077-1084, 1979. McGauley GA (1987) Abnormal intestinal permeability: An aetiological
factor in chronic psychiatric disorders. British Journal of Psychiatry
150:853-856. Playford RJ, Floyd DN, Macdonald CE, et al. (1999) Bovine
colostrum is a health food supplement which prevents NSAID induced gut
damage. Gut. 44:653-658. Rooney PJ, Jenkins RT, Buchanan WW. (1990) A short review
of the relationship between intestinal permeability and inflammatory joint
disease. Clinical and Experimental Rheumatology. 8:75-83. Sangild P. (1999) Intestinal Macromolecule Absorption in the
Fetal Pig after Infusion of Colostrum in Utero. Pediatric Research
. 45:595-602. Van der Hulst R, Van Kreel B, Meyenfeldt M, et al. (1993)
Glutamine and the preservation of gut integrity. Lancet. 341:1363-1365. Werbach MR. (1998) Intestinal health relieves rheumatoid arthritis. Nutrition Science News. 3:396. Walker WA. (1975) Antigen absorption from the small intestine and gastrointestinal disease. Pediatric Clinics of North America. 22:731-746. LactoferrinAbe H., Saito H, Miyakawa H, et al. (1991) Heat stability of bovine lactoferrin at acidic pH. Journal of Dairy Science. 74:65-71. Appelmelk BJ, An YQ, Geerts M, et al. (1994) Lactoferrin is
a lipid A-binding protein. Infection and Immunity. 62:2628-2632. Baker EN, Anderson BF, Baker HM, et al. (1994) Three-dimensional
structure of lactoferrin in various functional states. Lactoferrin:
Structure and Function. 1-12. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K,
Tomita, M. (1992) Identification of the bactericidal domain of lactoferrin.
Biochemica Biophys Acta 1121:130-136. Buchta R. (1991) Ovine lactoferrin: Isolation from colostrum
and characterization . Journal of Dairy Research. 211-218. Gutteridge J, Paterson S, Segal A, Halliwell, B. Inhibition
of lipid peroxidation by the iron-binding protein lactoferrin. Biochem.
Journal 199:259-261. Haridas M, Anderson BF, Baker HM, Norris GE, Baker EN. (1994)
X-ray structure analysis of bovine lactoferrin at 2.5 Angstrom resolution.
Lactoferrin: Structure and Function. 235-238. Harmsen MC, Swart PJ, de Bethune MP, et al. (1995) Antiviral
effects of plasma and milk proteins: lactoferrin shows potent activity
against both human immunodeficiency virus and human cytomegalovirus replication
in vitro. Journal of Infectious Diseases. 172:380-388. Hasegawa K, Motsuchi W, Tanaka S, Dosako S. (1994) Inhibition
with lactoferrin of in vitro infection with human herpes virus. Jpn.
Journal of Sci. Biol. 47:73-85. Ikeda M, Sugiyama K, Tanaka T, et al. (1998) Lactoferrin markedly
inhibits hepatitis C virus infection in cultured human hepatocytes. Biochemical
and biophysical research communications 245:549-553. Kawakami H. (1988) Effects of iron-saturated Lactoferrin on iron absorption. Agric. Biol. Chem. 52:903-908. Kussendrager KD. Effects of heat treatment on structure and iron-binding capacity of bovine lactoferrin. Indigenous Antimicrobial Agents of Milk - Recent Developments 133-146. Kwiat G. (1998) Lactoferrin. NutriCology in Focus. Levay PF, Viljoen M. (1980) Lactoferrin: A general review.
Haematologica 3:252-267. Li Y, Tan A, Vlassara T, Vlassara H. (1995) Antibacterial
activity of lysozyme and lactoferrin is inhibited by binding of advanced
glycation-modified proteins to a conserved motif. Nature Medicine.
1(10):1057-61. Lonnerdal B, Iyer S. (1995) Lactoferrin: molecular structure and biological function. Annual Review of Nutrition 15:93-110. Masaaki I. and et al. (1999) Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clinical and Experimental Metastasis. 17:35-40. Mikogami T. (1995) Effect of intracellular iron depletion
by picolinic acid on expression of the lactoferrin receptor in the human
colon carcinoma cell subclone HT29-18-C1. Biochemistry Journal.
308:391-397. Petschow B, Talbott R, Batema R. (1999) Ability of lactoferrin
to promote the growth of Bifidobacterium spp. in vitro is independent
of receptor binding capacity and iron saturation level. Journal of
Microbiology. 48:541-549. Polla B. (1999) Therapy by taking away: The case of iron.
Biochemical Pharmacology. 57:1345-1349. Saito H, Miyakawa H, Tamura Y, Shimamura S, Tomita M. (1991)
Potent bactericidal activity of bovine lactoferrin hydrolysate produced
by heat treatment at acidic pH. Journal of Dairy Science. 74:3724-3730.
Shin K, Yamauchi K, Teraguchi S, et al. (1998) Antibacterial
activity of bovine lactoferrin and its peptides against enterohaemorrhagic
E. coli O157:H7. Letters in Applied Microbiology. 26:407-411. Thaler C, Labarrere C, Hunt J, Mcintyre J, Faulk P. (1999)
Unique epitopes of lactoferrin expressed in human cytotrophoblasts involved
in immunologic reactions. Am J Obstet Gynecol. 181(2):460-7. Viani RM, Gutteberg TJ, Lathey JL, Spector SA. (1999)Lactoferrin
inhibits HIV-1 replication in vitro and exhibits synergy when combined
with zidovudine. AIDS. 13:1273-4. Vorland L, Ulvatne H, Andersen J, et al. (1999) Antibacterial
effects of lactoferricin B. Scandinavian Journal of Infected Disease
31:179-184. Zagulski T, Jarzabek Z, Zagulska A, Zimecki M. (1998) The
main systemic, highly effective mechanisms generated by lactoferrin in
mammals in vitro. Advances in Lactoferrin Research. 443:247-50. Yamauchi K, Tomita M, Giehl TJ, Ellison RT. Antibacterial
activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment.
Infection and Immunity 61:719-728, 1993. OtherAlmada A. (1999) Eclipsing Echinacea. Nutrition Business Journal. Amaducci L, (1988) Phosphatidylserine in the treatment of
Alzheimer's disease: results of a multicenter study. Psychopharmacology
Bulletin. 24(1):130-4. Brinkeborn R. (1999) Echinaforce and other Echinacea fresh
plant preparations in the treatment of the common cold. Phytomedicine.
Mar 6:1-6. Buchwald D. (1994) Comparison of Patients with Chronic Fatigue
Syndrome, Fibromyalgia, and Multiple Chemical Sensitivities. Archives
of Internal Medicine. 154(18):2049-53. Buescher E, McIlheran S. (1988) Antioxidant properties of
human colostrum. Pediatric Research. 24(1):14-9.
Chaumeil C, Liotet S, Kogbe O. (1994) Treatment of severe
eye dryness and problematic eye lesions with enriched bovine colostrum
lactoserum. Lacrimal Gland, Tear Film, and Dry Eye Syndromes. Adv Exp
Med Biol. 350:595-9. Cochran C, et al. (1998) Cetyl Myristoleate- A Unique Natural Compound Valuable in Arthritis Conditions. Townsend Letter for Doctors and Patients. D'Adamo P. (1998) Larch arabinogalactan is a novel immune modulator. http://www.dadamo.com/. da Camara, C. Glucosamine sulfate for osteoarthritis. Ann
Pharmacotherapy 32:580-587. Diehl, H. and May, E. (1994) Cetyl Myristooleate isolated
from swiss albino mice: an apparent protective agent against adjuvant
arthitis in rats. Journal of Pharmaceutical Sciences. 83(3):296-9. Dillehay D, Webb S, Schmelz
E, Merrill A. (1994) Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced
colon cancer in CF1 mice. Journal of Nutrition. 124(5):615-20. Gregory RL, Allansmith
MR. (1987)Local immune responses in the ocular and oral secretory compartments
of humans. Adv Exp Med Biol. 216B:1749-57. Gold B. Huesca, M, Sherman P, Lingwood C. (1993) Helicobacter
mustelae and helicobacter pylori bind to common lipid receptors in vitro.
Infection and Immunity. 61:2632-2638. Heaton P. (1990) Cryptosporidiosis and acute leukemia. Archives
of Disease in Childhood. 65:813-814. Litman B, Mitchell D. (1996) A role for phospholipid polyunsaturation
in modulating membrane protein function. Lipids. Suppl:S193-7. McKallip R. (1999)Tumor Gangliosides Inhibit the Tumor-Specific
Immune Response. The Journal of Immunology. 163:3718-3726. Melchart D, et al. (1998) Echinacea root extracts for the
prevention of upper respiratory tract infections: a double-blind placebo
controlled randomized trial. Archives of Family Medicine. 7:541-5. Opekun AR, El-Zaimaity HMT, Osato MS, et al. (1999) Novel
therapies for Helicobacter pylori. Aliment Pharmacol Ther. 13:35-41. Patton S, Canfield L, Huston G., Ferris A, Jensen R. (1990)
Carotenoids of human colostrum. Lipids. 25(3):159-65.
Rueda R, Maldonado J, Narbona E. Gil A. (1998) Neonatal Dietary
Gangliosides. Early Human Development. 53 Suppl:S135-47. Slebodzinski A. (1986) Perinatal Thyroid Activity in Farm
Animals and the Role of Iodocompounds in Maternal Milk. Endocrinologia
Experimentalis. 20:229-246. Slebodzinski A. (1983) Serum thyroid hormone levels in colostrum
deprived piglets and calves. Endocrinologia Experimentals. 17:263-270. Soslau G. (1982) The Loss of Sialic Acid And its Prevention
in Stored Human Platelets. Thrombosis Research. 26:443-55. Tibbits D. (1999) Use of cetyl myristoleate for arthritis and tendinitis in holistic veterinary medical practice. Journal of the American Holistic Veterinary Medical Association. 18:27-31. Vaughan E, Mollet B. (1999) Probiotics in the new millennium.
Nahrung. 43:148-153. Yu B, Kang C, Han J, Kim D. (1998) Can antioxidant supplementation
slow the aging process? BioFactors. 7:93-101. top of page
Rebornne First Colostrum Your First Food! In the first 72 hours after giving birth, a mother produces a very special, pre-milk breast fluid called colostrum. It contains numerous substances which protect the infant from infections and other diseases, and stimulates growth and over fifty different health-supportive processes. some of which last a life time. These powerful factors have been shown to be beneficial also to people of all ages.
All mammals produce colostrum ,however, cow (bovine) colostrum is the only animal form that can be utilized by humans. Since dairy cows produce more colostrum than is needed by the newborn calves, the excess can be processed for human use as a powder for children and adults. Bovine colostrum contains even more health supportive substances than human colostrum.
What About Colostrum for Children
Many babies today are not breast fed even in the first critical few days. They have no source of colostrum unless they are given a supplement, since no milk or baby formula contains this important substance. Infants, with a developing immune system, are vulnerable to bacteria and virus infections. They also need stimulation to many basic metabolic processes necessary during their rapid growth and their entry into the world outside the protective immunity of the mothers womb. Colostrum capsules may be easily opened and the powder sprinkled into baby formula and later into the child's food. What About Colostrum for Adults
As we age we produce less immune and growth factors that are needed to heal tissue damage and to fight disease. Colostrum can provide many of these important factors which are often included in anti-aging programs.
In addition to IgF-1 and TgF-A & B, Epithelial Growth Factor (EgF) regenerate muscle, nerve, bone and cartilage - affecting all of the structural cells of the body, and helping to increase the anabolic process of protein syntheses, build lean muscle tissue, and burn fat for energy.
Excellent source of sulfur micro-nutrients, including MSM, or Methyl Sulfonyl Methane. In fact, colostrum is one of the richest known sources of MSM. It also contains other powerful components including two of the most potent anti-inflammatory compounds known. This makes it far more powerful than the new sulfur-based remedies, as Glucosamine Sulfate, alone. Preparation of Rebornne First Colostrum ?
Pure bovine origin colostrum is harvested from controlled, healthy cows at a state licensed, New Zealand MAF AND USDA inspected, dairy. It is shown by laboratory testing to be free of bacteria, herbicides, pesticides, and antibiotics. It is collected in the 72 hours after the birth of the cows second calving at which time the highest concentration of immune and growth factors are present. It is then frozen and sent to a licensed food processing facility for processing as a powder, which is finally measured into Vegicaps? in an FDA and GMP registered manufacturing laboratory. Unlike many complex proteins, colostrum is not reduced to individual amino acids in the stomach because of natural digestive enzyme inhibitors. This permits colostrum to pass intact into the intestinal tract for absorption into the blood stream. Colostrum's Growth Factors
Colostrum's Immune Factors
1.IgA and IgG help to neutralize toxins and other unwanted invaders in the Lymphatic and circulatory systems. 2.IgD and IgE are highly antiviral. 3.IgM is a powerful bacteria fighter. 4.PRP (Polyproline-Rich-Peptides) help boost an underactive immune system and help restore the thymus gland, which produces the vital T-cells that fight viruses and antigens, to optimal functioning capability. PRP helps balance an overactive immune system as is present in autoimmune disease-conditions in which the body actually attacks itself. This may make colostrum helpful for illnesses such as:
5.Lactoferrin in numerous research studies has been shown to be a potent, broad-spectrum natural antibiotic and anti-viral agent. Lactoferrin is also a potent anti-oxidant which inhibits the harmful effects of free radicals. 6.Osteoclasts are cells which degrade bone, undermining its structure, creating the porosity and loss of bone strength called osteoporosis.Osteoblasts, on the other hand, are bone-building cells. As we age, the number of osteoblasts decreases and osteoclasts increase in number. This is especially true of post-menopausal women, as a decline in estrogen levels has been shown to lead to an increase in osteoclasts. 7.A study reported in the Journal of Natural Medicine shows that TgT-B which is found in nature only in colostrum, is naturally produced by the osteoblasts, the bone-building cells. The study also proved that TgF-B dramatically increased cell apoptosis (cell death) among the osteoclasts, the bone destroying cells. 8.The study suggests that TgF-B could help slow or even prevent the development of osteoporosis. Colostrum is the only readily available natural source of growth factors, including TgF-B. We therefore recommend that anyone who desires to positively affect bone density and strength, take colostrum on a regular basis. We also recommend that post-menopausal women see their health practitioner for tests of hormone levels. The research findings suggest that the combination of careful hormone replacement therapy with a daily intake of colostrum could be extremely effective against this common scourge among so many members of our society. To take advantage of the growth factors, take your Colostrum in capsule form on an empty stomach, 20 minutes before eating or taking other supplements, followed by a large glass of water which will help to "wash" the capsules through to the small intestine where they are best absorbed. Be aware that heat destroys Colostrum's effectiveness. Processing is critical and tablet formulations and formulations of colostrum intermixed with other herbs and nutrients can virtually destroy all of its effectiveness.
|
|||||||